{"entity":{"type":"insider","cik":"0001636385","url":"/insider/0001636385","json_url":"/insider/0001636385.json","name":"Smith Hunter C","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":21,"first":"2022-02-15","last":"2026-02-19","span_basis":"filed_date"},"name_variants":[{"name":"Smith Hunter C","source":"filing","n_filings":21,"first_seen":"2022-02-15","last_seen":"2026-02-19"}],"transactions":[{"id":6084968,"accession":"0001104659-26-017729","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001104659-26-017729","line_url":"/filing/0001104659-26-017729","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4385.0,"shares_display":"4,385","price_per_share":101.25523265678449,"price_display":"101.26","price_state":"stated","total_value":444004.1952,"total_display":"444,004.20","total_whole":"444,004","shares_owned_after":111897.0,"shares_owned_after_display":"111,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-19","filed_date":"2026-02-19","scope":"insider","n_lines":4},{"id":6084959,"accession":"0001104659-26-017729","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001104659-26-017729","line_url":"/filing/0001104659-26-017729","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3569.0,"shares_display":"3,569","price_per_share":101.37561378537406,"price_display":"101.38","price_state":"stated","total_value":361809.5656,"total_display":"361,809.57","total_whole":"361,810","shares_owned_after":117266.0,"shares_owned_after_display":"117,266","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider","n_lines":5},{"id":6226185,"accession":"0001104659-26-014546","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001104659-26-014546","line_url":"/filing/0001104659-26-014546","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1592.0,"shares_display":"1,592","price_per_share":98.22846005025126,"price_display":"98.23","price_state":"stated","total_value":156379.7084,"total_display":"156,379.71","total_whole":"156,380","shares_owned_after":118566.0,"shares_owned_after_display":"118,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-12","filed_date":"2026-02-12","scope":"insider","n_lines":4},{"id":6226154,"accession":"0001104659-26-014546","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-26-014546","line_url":"/filing/0001104659-26-014546","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2766.0,"shares_display":"2,766","price_per_share":98.61403109182936,"price_display":"98.61","price_state":"stated","total_value":272766.41,"total_display":"272,766.41","total_whole":"272,766","shares_owned_after":120558.0,"shares_owned_after_display":"120,558","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-11","filed_date":"2026-02-12","scope":"insider","n_lines":3},{"id":6226142,"accession":"0001104659-26-014546","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-014546","line_url":"/filing/0001104659-26-014546","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2713.0,"shares_display":"2,713","price_per_share":102.99648735716919,"price_display":"103.00","price_state":"stated","total_value":279429.4702,"total_display":"279,429.47","total_whole":"279,429","shares_owned_after":123624.0,"shares_owned_after_display":"123,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-10","filed_date":"2026-02-12","scope":"insider","n_lines":3},{"id":6109318,"accession":"0001104659-26-011651","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-26-011651","line_url":"/filing/0001104659-26-011651#line-4","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3381.0,"shares_display":"3,381","price_per_share":106.063,"price_display":"106.06","price_state":"stated","total_value":358599.003,"total_display":"358,599.00","total_whole":"358,599","shares_owned_after":125537.0,"shares_owned_after_display":"125,537","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-05","filed_date":"2026-02-06","scope":"insider"},{"id":6109315,"accession":"0001104659-26-011651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-26-011651","line_url":"/filing/0001104659-26-011651","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3247.0,"shares_display":"3,247","price_per_share":105.9886522328303,"price_display":"105.99","price_state":"stated","total_value":344145.1538,"total_display":"344,145.15","total_whole":"344,145","shares_owned_after":130665.0,"shares_owned_after_display":"130,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-04","filed_date":"2026-02-06","scope":"insider","n_lines":3},{"id":5043848,"accession":"0001104659-25-078815","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-078815","line_url":"/filing/0001104659-25-078815#line-4","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3477.0,"shares_display":"3,477","price_per_share":96.0,"price_display":"96.00","price_state":"stated","total_value":333792.0,"total_display":"333,792.00","total_whole":"333,792","shares_owned_after":116915.0,"shares_owned_after_display":"116,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-13","filed_date":"2025-08-14","scope":"insider"},{"id":5043839,"accession":"0001104659-25-078815","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-078815","line_url":"/filing/0001104659-25-078815#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24611.0,"shares_display":"24,611","price_per_share":96.3322,"price_display":"96.33","price_state":"stated","total_value":2370831.7742,"total_display":"2,370,831.77","total_whole":"2,370,832","shares_owned_after":116915.0,"shares_owned_after_display":"116,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-08-12","filed_date":"2025-08-14","scope":"insider"},{"id":4923117,"accession":"0001104659-25-067431","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-067431","line_url":"/filing/0001104659-25-067431","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":42120.0,"shares_display":"42,120","price_per_share":80.47854058641975,"price_display":"80.48","price_state":"stated","total_value":3389756.1295,"total_display":"3,389,756.13","total_whole":"3,389,756","shares_owned_after":116915.0,"shares_owned_after_display":"116,915","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-09","filed_date":"2025-07-11","scope":"insider","n_lines":3},{"id":4199028,"accession":"0001104659-25-055974","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-25-055974","line_url":"/filing/0001104659-25-055974","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23400.0,"shares_display":"23,400","price_per_share":61.4106995,"price_display":"61.41","price_state":"stated","total_value":1437010.3683,"total_display":"1,437,010.37","total_whole":"1,437,010","shares_owned_after":109929.0,"shares_owned_after_display":"109,929","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-30","filed_date":"2025-06-03","scope":"insider","n_lines":2},{"id":4724936,"accession":"0001104659-25-015325","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-015325","line_url":"/filing/0001104659-25-015325#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2215.0,"shares_display":"2,215","price_per_share":57.22,"price_display":"57.22","price_state":"stated","total_value":126742.3,"total_display":"126,742.30","total_whole":"126,742","shares_owned_after":109929.0,"shares_owned_after_display":"109,929","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-19","filed_date":"2025-02-19","scope":"insider"},{"id":4051998,"accession":"0001104659-25-014273","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-014273","line_url":"/filing/0001104659-25-014273","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":751.0,"shares_display":"751","price_per_share":56.38728362183755,"price_display":"56.39","price_state":"stated","total_value":42346.85,"total_display":"42,346.85","total_whole":"42,347","shares_owned_after":105556.0,"shares_owned_after_display":"105,556","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-12","filed_date":"2025-02-14","scope":"insider","n_lines":2},{"id":4198496,"accession":"0001104659-25-011674","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-25-011674","line_url":"/filing/0001104659-25-011674","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1296.0,"shares_display":"1,296","price_per_share":57.51007716049383,"price_display":"57.51","price_state":"stated","total_value":74533.06,"total_display":"74,533.06","total_whole":"74,533","shares_owned_after":106300.0,"shares_owned_after_display":"106,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-11","filed_date":"2025-02-11","scope":"insider","n_lines":2},{"id":4724875,"accession":"0001104659-25-009287","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-25-009287","line_url":"/filing/0001104659-25-009287#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1678.0,"shares_display":"1,678","price_per_share":59.43,"price_display":"59.43","price_state":"stated","total_value":99723.54,"total_display":"99,723.54","total_whole":"99,724","shares_owned_after":101186.0,"shares_owned_after_display":"101,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-04","scope":"insider"},{"id":2184233,"accession":"0001104659-24-036319","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-036319","line_url":"/filing/0001104659-24-036319#line-1","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15515.0,"shares_display":"15,515","price_per_share":39.22,"price_display":"39.22","price_state":"stated","total_value":608498.3,"total_display":"608,498.30","total_whole":"608,498","shares_owned_after":97939.0,"shares_owned_after_display":"97,939","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-19","filed_date":"2024-03-19","scope":"insider"},{"id":2128796,"accession":"0001104659-24-022540","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-022540","line_url":"/filing/0001104659-24-022540#line-4","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":709.0,"shares_display":"709","price_per_share":49.82,"price_display":"49.82","price_state":"stated","total_value":35322.38,"total_display":"35,322.38","total_whole":"35,322","shares_owned_after":79704.0,"shares_owned_after_display":"79,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-13","filed_date":"2024-02-13","scope":"insider"},{"id":2128791,"accession":"0001104659-24-022540","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-24-022540","line_url":"/filing/0001104659-24-022540#line-3","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1209.0,"shares_display":"1,209","price_per_share":51.38,"price_display":"51.38","price_state":"stated","total_value":62118.42,"total_display":"62,118.42","total_whole":"62,118","shares_owned_after":80413.0,"shares_owned_after_display":"80,413","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-13","scope":"insider"},{"id":2962548,"accession":"0001104659-24-010799","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-010799","line_url":"/filing/0001104659-24-010799#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1616.0,"shares_display":"1,616","price_per_share":45.06,"price_display":"45.06","price_state":"stated","total_value":72816.96,"total_display":"72,816.96","total_whole":"72,817","shares_owned_after":75215.0,"shares_owned_after_display":"75,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-05","scope":"insider"},{"id":8357734,"accession":"0001104659-23-124302","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-23-124302","line_url":"/filing/0001104659-23-124302#line-4","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20000.0,"shares_display":"20,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":800000.0,"total_display":"800,000.00","total_whole":"800,000","shares_owned_after":61406.0,"shares_owned_after_display":"61,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-06","filed_date":"2023-12-07","scope":"insider"},{"id":8357727,"accession":"0001104659-23-124302","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-124302","line_url":"/filing/0001104659-23-124302#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7026.0,"shares_display":"7,026","price_per_share":35.064,"price_display":"35.06","price_state":"stated","total_value":246359.664,"total_display":"246,359.66","total_whole":"246,360","shares_owned_after":61406.0,"shares_owned_after_display":"61,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-07","scope":"insider"},{"id":8119288,"accession":"0001104659-23-121648","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-121648","line_url":"/filing/0001104659-23-121648#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10974.0,"shares_display":"10,974","price_per_share":35.0224,"price_display":"35.02","price_state":"stated","total_value":384335.8176,"total_display":"384,335.82","total_whole":"384,336","shares_owned_after":61406.0,"shares_owned_after_display":"61,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-24","filed_date":"2023-11-28","scope":"insider"},{"id":7944823,"accession":"0001104659-23-119091","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-119091","line_url":"/filing/0001104659-23-119091#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":30.3811,"price_display":"30.38","price_state":"stated","total_value":364573.2,"total_display":"364,573.20","total_whole":"364,573","shares_owned_after":61406.0,"shares_owned_after_display":"61,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-16","scope":"insider"},{"id":8403271,"accession":"0001104659-23-022112","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-022112","line_url":"/filing/0001104659-23-022112#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":702.0,"shares_display":"702","price_per_share":26.87,"price_display":"26.87","price_state":"stated","total_value":18862.74,"total_display":"18,862.74","total_whole":"18,863","shares_owned_after":59406.0,"shares_owned_after_display":"59,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-14","filed_date":"2023-02-14","scope":"insider"},{"id":9223769,"accession":"0001104659-23-022062","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-022062","line_url":"/filing/0001104659-23-022062#line-1","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1413.0,"shares_display":"1,413","price_per_share":27.51,"price_display":"27.51","price_state":"stated","total_value":38871.63,"total_display":"38,871.63","total_whole":"38,872","shares_owned_after":57764.0,"shares_owned_after_display":"57,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-14","scope":"insider"},{"id":8429130,"accession":"0001104659-23-019830","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-019830","line_url":"/filing/0001104659-23-019830#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1398.0,"shares_display":"1,398","price_per_share":27.66,"price_display":"27.66","price_state":"stated","total_value":38668.68,"total_display":"38,668.68","total_whole":"38,669","shares_owned_after":57779.0,"shares_owned_after_display":"57,779","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-09","filed_date":"2023-02-13","scope":"insider"},{"id":6575448,"accession":"0001104659-22-077799","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-077799","line_url":"/filing/0001104659-22-077799#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7547.0,"shares_display":"7,547","price_per_share":4.08,"price_display":"4.08","price_state":"stated","total_value":30791.76,"total_display":"30,791.76","total_whole":"30,792","shares_owned_after":57614.0,"shares_owned_after_display":"57,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-01","filed_date":"2022-07-06","scope":"insider"},{"id":6171038,"accession":"0001104659-22-023951","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-023951","line_url":"/filing/0001104659-22-023951#line-2","is_derivative":false,"issuer_cik":"0001636385","issuer_name":"RHYTHM PHARMACEUTICALS, INC.","issuer_ticker":"RYTM","issuer_name_source":null,"issuer_url":"/issuer/0001636385","owner_cik":"0001636385","owner_name":"Smith Hunter C","owner_display_name":"Smith Hunter C","owner_url":"/insider/0001636385","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":833.0,"shares_display":"833","price_per_share":6.1,"price_display":"6.10","price_state":"stated","total_value":5081.3,"total_display":"5,081.30","total_whole":"5,081","shares_owned_after":40161.0,"shares_owned_after_display":"40,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-15","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":49,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":49,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":49},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001649904","name":"RHYTHM PHARMACEUTICALS, INC.","url":"/issuer/0001649904","role":"Officer (Chief Financial Officer)","n_filings":21,"first_seen":"2022-02-15","last_seen":"2026-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001636385","retrieved_at":"2026-08-24T15:26:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}